Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Pandion Therapeutics, Inc. (PAND)
|
|
Balance Sheet |
|
|
|
Standardized | As Reported |
Annual | Quarterly |
|
In millions, except per share items | Dec-31-20 | Sep-30-20 | Jun-30-20 | Dec-31-19 |
| 10-K | 10-Q | 10-Q | 10-K |
Assets |
Cash and equivalents | 219.9 | 232.3 | 105.7 | 16.0 |
Accounts receivable, net | 1.0 | 2.1 | 1.3 | 1.0 |
Other current assets | 3.1 | 3.0 | 3.4 | 3.0 |
Total current assets | 223.9 | 237.4 | 110.4 | 20.0 |
Property, plant, and equipment, net | 3.4 | 3.0 | 2.6 | 1.1 |
Total assets | 227.9 | 241.0 | 113.5 | 21.0 |
|
Accounts payable | 1.8 | 2.9 | 3.7 | 1.2 |
Accrued expenses | 3.3 | 4.1 | 2.3 | 1.5 |
Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
Other current liabilities | 3.8 | 4.7 | 10.7 | 4.4 |
Total current liabilities | 8.9 | 11.7 | 16.8 | 7.0 |
Long-term debt | | | 1.8 | 3.7 |
Other liabilities | 4.3 | 4.4 | 4.8 | 6.1 |
Total liabilities | 13.1 | 16.1 | 23.4 | 16.8 |
|
Shareholders' equity [+] | 214.7 | 224.8 | 90.1 | 4.2 |
Paid-in capital | 300.7 | 299.6 | | |
Retained earnings | -86.0 | -74.8 | -62.9 | -43.0 |
Tangible shareholders' equity | 214.7 | 224.8 | 90.1 | 4.2 |
|